Apotex Pulls Antitrust Suit Vs. Allergan Over Acular Patent

Law360, New York (January 12, 2004, 12:00 AM EST) -- Apotex and Novex withdrew their antitrust lawsuit against Allergan and Roche Palo Alto after losing a patent infringement suit against Allergan last week.

The lawsuit had been pending in the U.S. District Court for the Northern District of California.

The lawsuit was based on allegations concerning a patent infringement action brought by Allergan and Syntex LLC against the Apotex defendants over their plans to launch a generic version of Allergan's non-steroidal anti-inflammatory drug Acular.

Last week, U.S. District Court Judge Martin Jenkins held that the patent...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.